BIOMAT Database Logo BIOMAT Database Logo

Autoimmune hypoglycemia due to anti-insulin antibodies. 2018

Brenda Veiguela Blanco, and Marta Diéguez Felechosa, and Vanessa García Moreira
Sección de Endocrinología y Nutrición, Hospital Universitario de Cabueñes, Gijón, Asturias, España.

UI MeSH Term Description Entries
D007003 Hypoglycemia A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH. Fasting Hypoglycemia,Postabsorptive Hypoglycemia,Postprandial Hypoglycemia,Reactive Hypoglycemia,Hypoglycemia, Fasting,Hypoglycemia, Postabsorptive,Hypoglycemia, Postprandial,Hypoglycemia, Reactive
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D011384 Proinsulin A pancreatic polypeptide of about 110 amino acids, depending on the species, that is the precursor of insulin. Proinsulin, produced by the PANCREATIC BETA CELLS, is comprised sequentially of the N-terminal B-chain, the proteolytically removable connecting C-peptide, and the C-terminal A-chain. It also contains three disulfide bonds, two between A-chain and B-chain. After cleavage at two locations, insulin and C-peptide are the secreted products. Intact proinsulin with low bioactivity also is secreted in small amounts.
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D003927 Diet, Diabetic A course of food intake prescribed for patients, that limits the amount of foods with a high GLYCEMIC INDEX. Diabetic Diet,Diabetic Diets,Diets, Diabetic
D003981 Diazoxide A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group. Hyperstat,Proglycem

Related Publications

Brenda Veiguela Blanco, and Marta Diéguez Felechosa, and Vanessa García Moreira
[Autoimmune hypoglycemia syndrome with specific anti-human insulin antibodies].
January 1996, Medicina,
Brenda Veiguela Blanco, and Marta Diéguez Felechosa, and Vanessa García Moreira
Diabetes and hypoglycemia due to insulin antibodies.
May 1978, The American journal of medicine,
Brenda Veiguela Blanco, and Marta Diéguez Felechosa, and Vanessa García Moreira
Pseudoinsulinoma in a white man with autoimmune hypoglycemia due to anti-insulin antibodies: value of the free C-Peptide assay.
November 2014, American journal of clinical pathology,
Brenda Veiguela Blanco, and Marta Diéguez Felechosa, and Vanessa García Moreira
Autoimmune hypoglycemia in a type 2 diabetic patient with anti-insulin and insulin receptor antibodies.
May 2004, Diabetes care,
Brenda Veiguela Blanco, and Marta Diéguez Felechosa, and Vanessa García Moreira
Autoimmune hypoglycemia in a type 2 diabetic patient with anti-insulin and insulin receptor antibodies.
January 2004, Diabetes care,
Brenda Veiguela Blanco, and Marta Diéguez Felechosa, and Vanessa García Moreira
Severe hypoglycemia due to insulin autoimmune syndrome with insulin autoantibodies crossreactive to proinsulin.
January 2001, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association,
Brenda Veiguela Blanco, and Marta Diéguez Felechosa, and Vanessa García Moreira
Severe autoimmune hypoglycemia with insulin antibodies necessitating plasmapheresis.
January 2004, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
Brenda Veiguela Blanco, and Marta Diéguez Felechosa, and Vanessa García Moreira
A case of systemic lupus erythematosus presenting as hypoglycemia due to anti-insulin receptor antibodies.
November 2008, Rheumatology international,
Brenda Veiguela Blanco, and Marta Diéguez Felechosa, and Vanessa García Moreira
Antibodies to insulin receptor followed by anti-idiotype. Antibodies to insulin in child with hypoglycemia.
March 1987, Diabetes,
Brenda Veiguela Blanco, and Marta Diéguez Felechosa, and Vanessa García Moreira
Autoimmune haemolytic anaemia due to anti-phospholipid antibodies.
January 1991, Vox sanguinis,
Copied contents to your clipboard!